Factors Associated with Poor Response to Clozapine in Patients with Treatment-resistant Schizophrenia
Background: Clozapine (CLZ) is the drug of choice for the management of schizophrenia that does not respond to first-line treatments. 40%–70% of patients on CLZ do not have significant improvement and require augmentation. This study aimed to identify factors associated with inadequate response to C...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2025-07-01
|
| Series: | Current Medical Issues |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/cmi.cmi_41_25 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|